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Abstract
Background: While approximately 70% of chronic low back pain (CLBP) sufferers complain of sleep disturbance,
current literature is based on self report measures which can be prone to bias and no objective data of sleep
quality, based exclusively on CLBP are available. In accordance with the recommendations of The American Sleep
Academy, when measuring sleep, both subjective and objective assessments should be considered as the two are
only modestly correlated, suggesting that each modality assesses different aspects of an individual's sleep
experience. Therefore, the purpose of this study was to expand previous research into sleep disturbance in CLBP
by comparing objective and subjective sleep quality in participants with CLBP and healthy age and gender matched
controls, to identify correlates of poor sleep and to test logistics and gather information prior to a larger study.
Methods: 15 CLBP participants (mean age = 43.8 years (SD = 11.5), 53% female) and 15 healthy controls (mean
age = 41.5 years (SD = 10.6), 53% female) consented. All participants completed the Pittsburgh Sleep Quality
Index, Insomnia Severity Index, Pittsburgh Sleep Diary and the SF36v2. CLBP participants also completed the
Oswestry Disability Index. Sleep patterns were assessed over three consecutive nights using actigraphy. Total
sleep time (TST), sleep efficiency (SE), sleep latency onset (SL) and number of awakenings after sleep onset
(WASO) were derived. Statistical analysis was conducted using unrelated t-tests and Pearson's product moment
correlation co-efficients.
Results: CLBP participants demonstrated significantly poorer overall sleep both objectively and subjectively.
They demonstrated lower actigraphic SE (p = .002) and increased WASO (p = .027) but no significant differences
were found in TST (p = .43) or SL (p = .97). Subjectively, they reported increased insomnia (p =< .001), lower SE
(p =< .001) and increased SL (p =< .001) but no difference between TST (p = .827) and WASO (p = .055).
Statistically significant associations were found between low back pain (p = .021, r = -.589), physical health (p =
.003, r = -.713), disability levels (p = .025, r = .576), and subjective sleep quality in the CLBP participants but not
with actigraphy.
Conclusion: CLBP participants demonstrated poorer overall sleep, increased insomnia symptoms and less
efficient sleep. Further investigation using a larger sample size and a longer period of sleep monitoring is ongoing.
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Chronic low back pain (CLBP) is among the most preva-
lent of all health complaints, is associated with enormous
health care costs, reduced quality of life, and is almost
universally associated with insomnia [1]. Two recent stud-
ies reported that 55% of chronic low back pain (CLBP)
sufferers subjectively report impaired sleep after pain
onset [2], and over half of this population suffers from
moderate or severe co-morbid insomnia [3]. A study in
France investigating subjective sleep quality in 101 CLBP
patients found that their sleep was significantly altered
compared to that of healthy age, sex and height matched
controls [4].
The majority of previous research into sleep disturbance
and musculoskeletal pain has been based upon self-report
measures in heterogeneous patient groups (e.g. headache,
neck pain, back pain, fibromyalgia) [5-8]. The main diffi-
culty in interpreting these results is the variety of popula-
tions studied as individuals that present to an orthopaedic
out-patient clinic with back pain are likely different from
in-patients with chronic headaches. Therefore, further
studies of homogenous patient populations are needed to
form generalisations about sleep and pain and specific
clinical conditions [9].
The criterion standard for measuring sleep is polysomnog-
raphy (PSG) [10]: an objective measurement that assesses
actual physical and physiological processes during sleep-
activity periods. However, because of its inherent logisti-
cal complexity and expense, studies that document sleep
disturbance by PSG are infrequent in the literature and
have mostly concentrated on small samples of patients
with fibromyalgia [10]. Its use has been limited to one
study in sleep disturbance and CLBP, which found CLBP
participants reported significant levels of sleep distur-
bance as compared to controls, but all groups had equiv-
alent amounts of sleep and comparable sleep architecture
on PSG [11]. However, this study controlled for many fac-
tors other than pain including depression that may con-
tribute to the sleep complaints in this population. The
authors consequently reported that the absence of signs of
major sleep disturbance must not be interpreted as evi-
dence of a lack of a true sleep problem in CLBP but more
likely reflects control of these factors, as well as the diffi-
culty in measuring sleep. Additionally, PSG generally
requires that patients do not take CNS active medications
for two weeks prior to assessment. This requirement is a
stringent one and can be a limitation for many individuals
treated for chronic pain conditions, including low back
pain [10].
An alternate, less expensive and less obtrusive objective
method for detecting sleep is wrist actigraphy [10]. The
actigraph distinguishes between sleep and wakefulness
using activity counts as a proxy measure of sleep [12] and
is particularly useful as it does not require participants to
spend the night in an artificial sleep laboratory environ-
ment and allows for consecutive nights monitoring. It has
demonstrated reasonably high epoch by epoch (> 0.85)
and sleep efficiency agreement with PSG (> 0.80) [12].
Nonetheless, only one study in a mixed group of chronic
pain participants (including CLBP) has measured sleep
using both actigraphy and self report measures finding
that pain severity was associated with subjective sleep dis-
turbance but not actigraphy, for individuals reporting
high pain severity [8]. The American Sleep Academy rec-
ommends that both subjective and objective measures of
sleep are warranted in musculoskeletal pain research, as
the two are only modestly correlated [6,7] and they assess
different aspects of an individual's sleep experience
[13,14].
The purpose of this pilot study was to expand previous
research into sleep disturbance in CLBP by conducting
both subjective and objective assessments and to test
logistics and gather information prior to a larger study, in
order to improve the latter's quality and efficiency.
We hypothesised that CLBP patients would demonstrate
on actigraphy reduced total sleep time (TST), increased
sleep onset latency (SL), increased waking after sleep
onset (WASO) and decreased sleep efficiency (SE), and on
subjective measures, poorer overall sleep quality and
higher insomnia scores, compared to healthy age and gen-
der matched controls. It was suggested that there would be
a moderate to strong association between pain, quality of
life, disability and sleep quality in CLBP participants and
that moderate associations would be found between sub-
jective and objective sleep measures.
Methods
A cross sectional study involving 15 control participants
and 15 CLBP participants utilising objective and self
report methods of measuring sleep quality in free living
conditions was conducted.
Participants
The control group was recruited via poster advertisement
in a university campus. Posters which described the nature
of the study and provided a contact number were placed
throughout the campus. Following initial contact by the
volunteers, telephone screening for eligibility was con-
ducted. Volunteers were recruited if they were aged
between 18 and 65 years, were pain-free, currently of good
health and reported no diagnosed sleep disturbances.
The CLBP participants were recruited from a physiother-
apy waiting list in a large city hospital. Twenty eightPage 2 of 9
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to take part in the study. Participants were included if they
had a history of low back pain of more than 12 weeks
duration and excluded if they had any serious spinal
pathology, major active psychotic illness and/or a primary
diagnosis of insomnia.
All potential participants were invited to meet the
researcher and received written and verbal information
about the study. An appointment was made for one week
later for each subject to provide informed consent, partic-
ipate in a baseline assessment and receive the study
instructions. Ethical approval was obtained from the Uni-
versity Ethics Committee and the participating hospitals
Medical Ethics Committee.
Procedures
After initial screening and enrolment, study participants
completed a baseline assessment which took approxi-
mately 45 minutes. Gender, age, weight, height, BMI and
medication usage were also recorded. All participants
completed self report measures of sleep quality (Pitts-
burgh Sleep Quality Index [15], Insomnia Severity Index
[16], quality of life (SF36v2) [17] and pain (bodily pain
scale of the SF36v2) [17], and for the CLBP participants
functional disability, measured by the Oswestry Disability
Index (ODI) [18]. All participants then underwent three
consecutive nights of actigraphy monitoring, while simul-
taneously completing a daily sleep log; the Pittsburgh
Sleep Diary [19].
Outcome Measures
Objective Sleep Assessment - Actigraphy
Sleep patterns were objectively assessed using the Acti-
watch (registered trademark of Mini Mitter Company,
Cambridge Neurotechnology Ltd. UK): a compact, light
weight, wrist worn electronic device that measures and
records physical activity. The Actiwatch contains a sensor
capable of detecting acceleration in two planes. It is sensi-
tive to 0.01 g and integrates the degree and speed of
motion and produces an electrical current with varying
magnitude. An increased degree of speed and motion pro-
duces an increase in voltage. The watch converts this sig-
nal and stores it as activity counts. The maximum
sampling rate is 32 Hz. Sleep variables are extracted from
this activity data using the Actiwatch Activity & Sleep
Analysis 5 [20].
The watch was worn by the participating participants on
their non-dominant wrist. The participants were
instructed to press a button on the watch to activate an
individual event marker on four occasions: Bed Time, Get
Up Time, Sleep Start and Sleep End. The sleep log (PSD)
completed by each subject was used to verify and validate
the markers on the actigraphy data. The watch was set to
record the number of activity counts during 15 second
intervals (epochs).
Sleep variables included total sleep time (TST), awaken-
ings after sleep onset (WASO), sleep onset latency (SL)
and sleep efficiency (SE). TST represented the total
amount of sleep in minutes received from onset of sleep
to onset of awakening. WASO referred to the time (min-
utes) spent awake after sleep onset had occurred. SL was
the time period measured from "lights out" or "bedtime"
to the beginning of sleep, and SE defined as the propor-
tion of sleep in the period potentially filled by sleep: ratio
of total sleep time to time in bed as a percentage, where a
SE less than 85% is considered to be indicative of sleep
disturbance [21].
Self report assessment
Pittsburgh Sleep Quality Index
The Pittsburgh Sleep Quality Index (PSQI) measured ret-
rospective sleep quality and disturbances [15]. The PSQI
discriminates between good and poor sleepers and pro-
vides a brief, clinically useful assessment of multiple sleep
disturbances. It comprises of 19 items that generate seven
component scores. The sum of these scores (range 0 - 21)
yield a global measure of sleep quality, with higher scores
indicating increasingly poor sleep (> 5 indicative of sleep
disturbance). The components assess a broad range of
domains associated with sleep quality including duration
of sleep, sleep latency, the frequency and severity of spe-
cific sleep related problems and the perceived impact of
poor sleep on daytime functioning. This questionnaire is
perhaps the most widely used general measure of sleep
available and the strengths of this instrument are its range
of coverage of multiple dimensions of sleep quality, its
flexibility as a brief clinical tool and its demonstrated
validity and utility in chronic pain research [22].
The Insomnia Severity Index
The Insomnia Severity Index (ISI) measures insomnia
severity [16]. While not specifically developed for pain
patients, scale development included a heterogenous
group of patients with insomnia secondary to pain condi-
tions [23]. It comprises seven items assessing insomnia
severity, generating a total that ranges from 0-28 (with
higher scores indicative of more severe insomnia).
Following the recommended score interpretation guide-
lines, a total score of 0-7 indicates 'no clinically significant
insomnia', 8-14 'sub-threshold insomnia', 15-21 'clinical
insomnia (moderate severity)' and 22-28 'clinical insom-
nia (severe)' [15]. The cut off level of 14 has optimal sen-
sitivity (94%) and specificity (94%) in distinguishing a
group of adults diagnosed with primary insomnia from
those without [24].Page 3 of 9
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The Pittsburgh Sleep Diary (PSD) was used to quantify
subjectively reported sleep and wake behaviours [19]. It is
divided into two daily questionnaires completed at 'bed-
time' and 'waketime'. The timing and duration of various
daytime and sleep-wake parameters and activities are
hand entered by the participant.
The bedtime component comprises of six general items;
(i) the timing of meals, (ii) consumption of caffeine, (iii)
alcohol and (iv) tobacco products, (v) medication use and
(vi) and the timing and duration of exercise and nap peri-
ods. The daytime component gathers data on (i) bedtime,
(ii) 'lights out time', (iii) sleep latency, (iv) final wake-
time, (v) method of final awakening, (vi) frequency of
nightly awakenings, (vii) wake after sleep onset time,
(viii) reasons for nightly awakenings, (ix) sleep quality
and (x) mood on final wakening and (xi) alertness on
final wakening.
In addition to categorical and frequency data generated by
the night time questionnaire, the wake-time question-
naire permits the calculation of standard continuity
parameters as follows:
(i) sleep latency (SL), minutes; ranges from 0 to total time
in bed (TIB); (ii) frequency of nightly awakenings; ranges
from 0 to 5+; (iii) total sleep time (TST), calculated by the
formula: (TST = (TIB - SL + WASO)); ranges from 0 to TIB;
(v) sleep efficiency percentage (SE), calculated by the for-
mula, SE = TST/TIB.
The PSD was developed from three investigations includ-
ing samples of participants with sleep disorders, healthy
adult controls, chronic pain patients and older adults. Sig-
nificant long term test-retest correlation coefficients for
the wake-time variables with a mean inter-test interval of
22 months (range; r = 0.59 - 0.81) have been reported
[25].
There are no formally established research diagnostic cri-
teria for sleep diary estimates of sleep continuity. Com-
monly used clinical and research criteria for symptom
severity are as follows: mean sleep latency and/or wake
after sleep onset time > 30 minutes and mean sleep effi-
ciency percentage < 85% [26].
Assessment of Quality of Life and Pain
SF-Item Short-Form 36 Health Survey (standard) Version 2.0 
(SF36v2)
The SF-36 (36-Item Short-Form Health Survey) was used
to measure overall health status, functional status and
health-related quality of life [17]. Two standardised sum-
mary scores are calculated from eight sub-scores; the Phys-
ical Component Score (PCS) and the Mental Component
Score (MCS). The bodily pain scale of the SF36v2 was
used to measure pain severity. 'How much bodily pain
have you had during the past four weeks?' There are six
possible answers varying from none to very severe. [17].
Assessment of Low Back Pain-related Disability
Oswestry Disability Index
The Oswestry Disability Index (ODI) is a self adminis-
tered valid and reliable questionnaire used in the field of
spinal research to indicate the extent to which a person's
activities of daily living are disrupted or restricted by low
back pain [18]. It consists of ten items and is completed in
reference to the patient's functional status 'today'. Each
item is scored 0-5; the total score is multiplied by two and
expressed by a percentage, with the higher the score, the
higher the level of disability.
Statistical Analysis
Analytic data files were created using SPSS software and all
analyses were conducted using SPSS V12.0 for Windows
(SPSS Inc., Chicago, IL). Descriptive statistics were com-
puted for demographic and health characteristics and
each sleep variable and summarised using mean values.
Group differences on categorical variables (physical activ-
ity, smoking, caffeine consumption and medication) were
evaluated using x2 analysis.
Preliminary assumption testing was conducted to check
normality, linearity, univariate and multivariate outliers,
homogeneity of variance-covariance matrices and muti-
collinearity, with no serious violations noted. Unrelated t-
tests were used to compare mean values for both objective
and subjective sleep parameter scores between CLBP par-
ticipants and healthy controls. Effect sizes (eta squared)
were interpreted using Cohen's guidelines with > 0.2
being a small effect size, > 0.5 a medium effect size and >
0.8 a large effect size.
To assess the association between subjective and objective
sleep measures, and to determine if there was any rela-
tionship between sleep, pain, quality of life and/or disa-
bility, Pearson's product moment correlation co-efficients
were performed.
Results
Demographics and Health Characteristics
In total, 31 healthy individuals volunteered for the study.
The 15 healthy participants (n = 8 female) aged between
24 and 60 years (38.46 ± 10.57) chosen to participate
were those closest to the CLBP participants in gender and
age. Out of 28 CLBP participants invited to participate, 15
(n = 8 female) aged between 26 and 64 years (45.0 ±
11.53) were recruited. Sample demographics and health
characteristics are shown in Table 1. Among the CLBP par-
ticipants, 86% (n = 13) reported using prescription medi-Page 4 of 9
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antidepressants compared to none of the control group (p
= .032). In both groups, 26% (n = 4) were medicated to
control high blood pressure and/or high cholesterol. Two
thirds of the control group (n = 10) reported participating
in regular exercise, whereas all of the CLBP participants
exercised but to a significantly lesser intensity than the
healthy controls (p = .007). Significantly more CLBP par-
ticipants smoked cigarettes (p = .032), and both groups
consumed equal amount of caffeine ( one cup per day).
Analyses indicated no significant differences between
groups in age (p = .117), gender (p = 1.0), weight (p =
.29). However, compared to the healthy controls, CLBP
participants reported significantly poorer quality of life on
both subscales of the SF36 (p =< .001) and more severe
pain (p =< .001).
Sleep Assessment
The following parameters were derived both objectively
from the computer-scored actigraph data and subjectively
from the Pittsburgh sleep diary: TST, SE, SL and WASO.
Additionally, global sleep quality and insomnia severity
were derived from the PSQI and ISI questionnaires respec-
tively.
Objective Sleep Assessment
Table 2 presents the mean values, standard deviations and
confidence intervals for each actigraphic sleep variable by









38.5 (10.57) 45.0 (11.53) -1.617 .117 -1481 - 1.74
Gender
% (n) female
53.3 (n = 8) 53.3 (n = 8) 1.00
Weight
mean (SD)
74.0 (10.69) 80.7 (21.12) - 1.090 .285 -19.39 - 6.1
Physical Activity % (n) .007†
None 33.3 (5) 00.0 (0)
Low 20.0 (3) 46.7 (7)
Moderate 13.3 (2) 46.7 (7)
High 33.3 (5) 06.6 (1)
Smoker
% (n)
0 (0) 26.6 (4) .032†
Caffeine
% (n)
(> 1 cup per day)
86.6 (13) 86.6 (13) 1.00
Medication
% (n)
Pain 0 (0) 86.6 (13) <.001†
Sleep 0 (0) 0 (0) 1.00
Antidepressants 0 (0) 26.6 (4) .032†
Others 26.6 (4) 26.6 (4) 1.00
SF 36
mean (SD)
MCS 57.3 (3.3) 44.6 (10.1) 4.64 <.001† 6.94 - 18.52
PCS 56.4 (3.1) 44.0 (6.3) 6.93 <.001† 8.75 - 16.12
Bodily Pain 61.8 (.87) 39.9 (8.1) 10.35 <.001† 17.36 -26.42
† = p < 0.05 MCS: Mental Combined ScorePCS: Physical Combined Score
Table 2: Differences between mean scores on actigraphic sleep variables for healthy controls and CLBP subjects
Control Group CLBP Group t-value p-value CI (95%)
Variable
Total sleep time (mins) mean (SD) 399.13 (40.8) 381.66 (73.5) .805 .428 -27.01-61.93
Sleep efficiency (%) mean (SD) 85.8 (4.4) 77.8 (7.8) 3.45 .002† 3.25 - 12.84
Sleep onset Latency (mins) mean (SD) 9.43 (10.2) 9.28 (11.1) .036 .972 -8.11 - 8.4
Awakenings after sleep onset (mins) mean (SD) 7.4 (8.06) 24.4 (30.39) -2.094 .055 -34.22-.2162Page 5 of 9
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ence between CLBP participants and healthy controls in
SE (t = 3.45, p = .002) and WASO (t = -2.33, p = .027). No
significant differences were found in TST (t = .805, p =
.428) or SL (t = .036, p = .97). Actigraphy recordings dem-
onstrated that both groups took approximately nine and
a half minutes to fall asleep after lights out (SL) and slept
for similar amounts of time i.e. approximately six hours
50 mins of estimated sleep per night (TST).
Subjective Sleep Assessment
Table 3 presents the subjective data. There was a statisti-
cally significant difference in self-report sleep onset
latency (t = -4.19, p =< .001) and sleep efficiency (t = 4.85,
p =< .001) Mean scores indicated that CLBP participants
reported significantly lower sleep efficiency scores (mean
(SD) = 73.4% (16.5)) than the healthy controls (mean
(SD) = 95.3%, (5.8)), and significantly higher sleep onset
latency times, up to three times longer (CLBP; mean =
45.3 mins, (27.7)) and controls; mean = 11.73 minutes
(14.2)). There was no difference between groups in total
sleep time (t = .220, p = .827) or number of minutes
awake after sleep onset (t = -2.094, p = .053).
Global sleep quality, as measured by the PSQI was
reported to be significantly poorer in the CLBP group
compared to the control group. In total, 86.6% (n = 13)
of the CLBP group scored > 5 on the PSQI, indicative of
poor sleep quality, compared to only 6.6% (n = 1) of the
control group (p = <0.001). Over half of the CLBP partic-
ipants (n = 8) reported threshold clinical insomnia (> 13
on ISI) compared to none of the healthy adults (p =<
.001) and all CLBP participants reported multiple night
time awakenings (mean (SD) = 2.6(1.5) wakening bouts).
Association between Subjective and Objective Sleep 
Variables
Significant associations were found between self report
and actigraphic total sleep time in the control (r = .78, p =
.01) and the CLBP groups (r = .80, p = <0.001; Table 4).
Subjective and actigraphically measured sleep latency
were significantly correlated in the control group (r = .73,
p = .002), but only a small non-significant association was
found in the CLBP group (r = .34, p = .25). There was no
correlation between subjective and objectively measured
WASO in either group (control: r = .006, p = .99, CLBP: r
= .072, p = .80). There was a moderate association
between self reported and actigraphic sleep efficiency in
the control group (r = .42, p = .12), with better subjective
sleep quality associated with higher sleep efficiency
scores. However, no relationship was found between sub-
jective and objective sleep efficiency in the CLBP partici-
pants (r = .28, p = .30).
Relationship between Pain, Quality of Life, Disability and 
Sleep Measures
In the control group, only the Mental Combined Score
(MCS) of the SF36v2 was associated with sleep. There was
a strong association between the MCS and actigraphy total
sleep time (r = .61, p = .017), and a weaker association
with sleep efficiency (r = -.49, p = 0.056). Neither pain nor
the Physical Component Score of the SF36v2 were signif-
icantly associated with any sleep variables in this group.
In the CLBP group, there was a strong relationship
between pain and objectively measured sleep but no rela-
tionship with quality of life or disability. Strong statisti-
cally significant relationships were found between the self
report PSQI global score and pain (r = -.59, p = .021), the
physical component score of the SF36v2 (r = -.71, p =
.003), and functional disability (r = .58, p = .025). Similar
relationships were found between the ISI score and pain
(r = -.74, p = .001), the physical component score of the
SF36v2 (r = -.57, p = .026), functional disability (r = .64,
p = .010) and sleep efficiency derived from the PSD (r = -
.52, p = .05). There was also a strong statistically signifi-
cant relationship between both objectively (r = .62, p =
.014) and subjectively (r = .54, p = .039) measured sleep
efficiency and the physical combined score of the SF36v2,
with a higher PCS correlating with better sleep efficiency.
Discussion
This study has confirmed that CLBP participants subjec-
tively report higher levels of sleep disturbance compared
to age and gender-matched controls, and for the first time
has compared self report to objective measurement find-
ing a significantly higher level of subjective than objective
levels of sleep disturbance in this population. Although
small, the sample was representative of the majority of
CLBP patients managed at out-patients clinics, in that
Table 3: Differences between mean scores (SD) on subjective sleep variables for healthy controls and CLBP subjects
Control Group CLBP Group t-value p-value CI (95%)
Variable
Total sleep time (mins) mean (SD) 439.33 (42.6) 434.33(76.9) .220 .827 -41.5 - 51.52
Sleep efficiency (%) mean (SD) 95.3 (5.8) 73.4 (16.5) 4.849 <.001 12.39 - 31.41
Sleep onset latency (mins) mean (SD) 11.7 (4.3) 45.3 (27.7) -4.185 <.001 -50.3 - -16.89
Awakenings after sleep onset (mins) mean (SD) 7.4 (8.06) 24.4 (30.39) -2.094 .053 -34.22- .2162Page 6 of 9
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toms, a higher percentage were women and the majority
were taking some form of prescription analgesia at the
time of initial evaluation [27].
CLBP participants were found to have poorer overall sleep
quality, with higher levels of sleep disturbance and
insomnia on subjective measures and lower overall sleep
quality on actigraphy compared with healthy age and gen-
der matched controls. The high prevalence of self reported
perceived sleep disturbance in CLBP patients found in this
study supports previous research in chronic pain popula-
tions using subjective measures [5-8,28,29]. Furthermore,
the objective measurement of sleep disturbance supple-
ments the evidence base, finding 87% of CLBP partici-
pants reported poor sleep quality and over half reported
threshold clinical insomnia, compared to the control
group who reported 7% poor sleep quality and no clinical
insomnia.
Actigraphic measurement showed no difference between
the CLBP participants and the controls in total sleep time
at seven hours per night, or in sleep onset latency taking
an average of 10 minutes. These findings were consistent
with previous studies investigating sleep quality in adoles-
cents with chronic pain [30], but inconsistent with actig-
raphy studies of adults with chronic pain, who reported
shorter overall sleep time, ranging from 4.9 to 5.9 hours
[8,31]. However, similar to previous work, awakenings
after sleep onset were more frequent in the CLBP partici-
pants than controls [8,31]. This is the first study to utilise
a discrete CLBP population, and the findings suggest that
although CLBP patients wake frequently during the night,
they sleep for longer time periods than patients with other
chronic musculoskeletal conditions and for the same
duration as healthy age and gender matched individuals.;
the reason for this requiring further investigation.
Subjectively the CLBP patients reported their sleep onset
latency to be four times longer than actigraphy measures
which is consistent with several studies that found sleep
latency was one of the most frequent problems associated
with chronic pain, with ranges from 20 to 102 minutes
reported [1,2,7]. By interpreting most self report variables
of sleep, the CLBP participants in this study had overall
sleep quality that was comparable to other studies of
patients with chronic pain [2,3,6-8,10,11].
Both self report and actigraphy revealed sleep efficiencies
within the normal parameters ( 85%) for the control par-
ticipants. However, the CLBP participants' sleep efficiency
was well below the 85% criterion used to differentiate
between good and bad sleepers [26]. Similarly, sleep effi-
ciency values ranging from 75% to 87% have been found
in other chronic pain studies [8,19,31,32]. The use of
actigraphy in this study draws attention to the discrepan-
cies that can occur with reliance on one type of measure-
ment alone and emphasised the importance of including
both subjective and objective measurement for complete,
accurate sleep assessment.
In this study, the association between the subjective and
objective measures varied significantly between both
sleep variables groups. There was no association between
the measures of sleep onset latency and sleep efficiency in
the CLBP group, with self-report sleep onset latency being
reported to a greater extent and sleep efficiency much
lower. In contrast, control group self-reported sleep onset
latency (r = .73) and sleep efficiency (r = .42) were
strongly associated with actigraph measures. Discrepan-
cies between self reporting and objective measurement of
sleep have been previously reported [9,28,33,34] in sev-
eral clinical populations. For example, adult cystic fibrosis
patients reported higher sleep latency scores and lower
sleep efficiency scores although actigraph measures
revealed no differences [34]. Similarly, adults with noctur-
nal asthma reported reduced overall sleep but not
increased night time awakenings even though polysom-
nographic assessment showed differences in sleep effi-
ciency, latency and awakenings [33]. A study investigating
Table 4: Relationship between objectively and subjectively measured sleep variables
Objective Subjective r-value p-value
Control Group (n-15)
Total Sleep Time (mins) mean (SD) 399.13 (40.8) 439.33 (42.6) 0.778 <.001 †
Sleep Efficiency (%) mean (SD) 85.83 (4.4) 95.33 (5.8) 0.417 .42
Sleep onset Latency (mins) mean (SD) 9.43 (10.2) 11.73 (14.2) 0.730 <.002 †
Awakenings after Sleep Onset (mins) mean (SD) 32.0 (9.22) 7.4 (8.06) .006 .984
CLBP Group (n = 15)
Total Sleep Time (mins) mean (SD) 434.33 (76.9) 381.66 (73.5) 0.795 <.000†
Sleep Efficiency (%) mean (SD) 73.43 (16.5) 77.81 (7.8) 0.298 .33
Sleep onset Latency (mins) mean (SD) 45.33 (27.7) 9.28 (11.1) 0.343 .251
Awakenings after Sleep Onset (mins) mean (SD) 43.3 (15.8) 24.4 (30.4) .072 .798
† p < 0.000Page 7 of 9
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and actigraphs provided similar estimates of total sleep
time, time awake after sleep onset and sleep efficiency, but
differed in sleep latency and nocturnal awakenings [8].
Our results indicate that the subjective and objective find-
ings differ to a great extent and that if sleep analysis was
based exclusively on one measure over the other, the
extent of the sleep disturbance in this population would
be inaccurate. It therefore highlights the importance of
using an objective assessment tool, such as the actigraph,
as an adjunct to self report measures. Future studies of
sleep quality and CLBP should be informed by this fact
and should employ a detailed clinical interview and
objective assessment to provide an accurate picture of
overall sleep quality in this population.
The significance of the inconsistencies between the sub-
jective and objective sleep variables in the CLBP group
was especially obvious when investigating their associa-
tion with pain, quality of life and disability. Only signifi-
cant correlations between the clinical measures and sleep
variables were observed with self report methods of
assessment: the corresponding correlations with the acti-
graph derived variables were low and non-significant,
again emphasising the importance of utilising both self-
report and objective measurement to establish accurate
relationships between sleep and other health variables.
As demonstrated, the subjective measures of sleep rather
than objective are more consistent with pain, quality of
life and disability measures and may incorporate negative
subject bias and fears about sleep. Future research may
establish differing clinical implications of poor sleep that
is identified by subjective versus actigraphy measure, but
preliminary investigation into the clinical correlates of
sleep quality in CLBP participants from this study suggest
that self report sleep quality is associated with pain and
reduced physical function.
The strengths of this study include the use of both subjec-
tive and objective sleep measures and an age and gender
matched healthy comparison group. Also, it is the first
study that has investigated sleep disturbance both subjec-
tively and objectively in one specific group of patients;
chronic low back pain sufferers. However, as it was a pilot
study, its principle limitation was that the sample size was
small and therefore underpowered to identify smaller
effects. Further investigation is now ongoing in a larger
sample size over a longer period of time.
Conclusion
The findings of this study serve to highlight the signifi-
cance of the problem of sleep disturbance for CLBP
patients and have important clinical implications for its
assessment. The rate of self perceived poor sleep is very
common in CLBP patients attending for clinical treat-
ment, however, very little is understood about the rela-
tionship between CLBP and sleep disruption. Initial
assessment of these patients should include sleep and
where possible, a combination of both self-report and
objective measures should be employed. Because the
direction of causation between pain and sleep disturbance
is still unclear and a recent perspectives indicate that poor
sleep can interfere with pain processing [35], effective
interventions to tackle sleep disturbance, such as cognitive
behavioural therapy [36] should be included the overall
management of the CLBP patient, to optimise treatment
outcome.
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